Head and Neck Cancer Trial, Recruiting NCT06905561 Sponsor: The Second Affiliated Hospital of Hainan Medical University Condition: Head and Neck Cancer
Back to Head And Neck Cancer

Head and Neck Cancer Trial, Recruiting

NCT06905561
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years of age or older (male or female)
  • You are physically able to carry out daily activities with little or no difficulty (confirm with trial site)
  • You have been diagnosed with a specific type of cancer affecting the throat, nose, voice box, sinuses, salivary glands, or breast, and your treatment plan includes a radiation dose of at least 50 Gy
  • Your skin in the area to be treated is currently healthy, with no radiation-related skin damage and good skin condition
  • Your blood test results are within acceptable ranges, showing healthy levels of red blood cells, white blood cells, and platelets, without having had a blood transfusion in the past 14 days
  • Your liver function tests are within acceptable limits
  • Your kidney function is within normal range
  • Your blood clotting ability is within acceptable limits
  • Your heart muscle enzyme levels are normal
  • You are willing and able to sign a consent form and follow the trial's requirements

Who may not be able to join:

  • Women who are pregnant or currently breastfeeding
  • Anyone who has previously had a reaction or allergy to any ingredient in the product being tested
  • Anyone with serious heart or lung conditions, such as unstable chest pain, significant heart failure, recent heart attack, or severe breathing disease
  • Anyone currently experiencing an active inflammatory skin condition, such as eczema, contact dermatitis, psoriasis, or similar skin diseases
  • Anyone with a known condition that slows down skin healing, such as diabetes or severe kidney failure
  • Anyone whose skin has broken down as a direct result of their cancer

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 19946610752

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
The Second Affiliated Hospital of Hainan Medical University
Registry
ClinicalTrials.gov
Start date
13 February 2025
Est. completion
30 June 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Incidence of development of grade ≥ 2 RID

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov